CAS 2609-46-3|Amiloride

Introduction:Basic information about CAS 2609-46-3|Amiloride, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameAmiloride
CAS Number2609-46-3Molecular Weight229.62700
Density2.11g/cm3Boiling Point628.1ºC at 760 mmHg
Molecular FormulaC6H8ClN7OMelting Point/
MSDS/Flash Point333.7ºC

Names

Nameamiloride
SynonymMore Synonyms

Amiloride BiologicalActivity

DescriptionAmiloride is a relatively selective inhibitor of the epithelial sodium channel (ENaC), used in the management of hypertension and congestive heart failure.
Related CatalogSignaling Pathways >>Membrane Transporter/Ion Channel >>Sodium ChannelResearch Areas >>Metabolic Disease
Target

Sodium channel

In VitroAmiloride blocks δβγ channels with an IC50 of 2.6 μM (58, 71, 75, 134, 148). The Ki of amiloride for δβγ ENaC is 26-fold that of αβγ channels (0.1 μM for αβγ ENaC). Amiloride blockade of δβγ ENaC is much more voltage dependent compared with the αβγ channel. The Ki of amiloride for δαβγ channels is 920 and 13.7 μM at -120 and +80 mV, respectively, which significantly differs from that of both αβγ and δβγ channels[1]. Amiloride is a relatively selective inhibitor of the epithelial sodium channel (ENaC) with an IC50 (the concentration required to reach 50% inhibition of an ion channel) in the concentration range of 0.1 to 0.5 μM. Amiloride is a relatively poor inhibitor of the the Na+/H+ exchanger (NHE) with an IC50 as low as 3 μM in the presence of a low external [Na+] but as high as 1 mM in the presence of a high [Na+]. Amiloride is an even weaker inhibitor of the Na+/Ca2+ exchanger (NCX), with an IC50 of 1 mM. Amiloride (1 μM) and submicromolar doses of Benzamil (30 nM), doses known to inhibit the ENaC, inhibit the myogenic vasoconstriction response to increasing perfusion pressure by blocking the activity of ENaC proteins. Amiloride completely inhibits Na+ influx in doses known to be relatively specific for ENaC (1.5 μM) in vascular smooth muscle cells (VSMC)[2].
In VivoAmiloride (1 mg/kg/day) subcutaneously is found to reverse the initial increases in collagen deposition and prevent any further increases in the DOCA-salt hypertensive rat. Amiloride delays the onset of proteinuria and improved brain and kidney histologic scores in the saline-drinking, stroke-prone spontaneously hypertensive rats (SHRSP) compared with controls. Amiloride antagonizes or prevents actions of aldosterone in these cells and in cardiovascular and renal tissues in animals with salt-dependent forms of hypertension[2]. 
References

[1]. Ji, H.L., et al. delta ENaC: a novel divergent amiloride-inhibitable sodium channel. Am J Physiol Lung Cell Mol Physiol, 2012. 303(12): p. L1013-26.

[2]. Teiwes J, et al. Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride. Am J Hypertens. 2007 Jan;20(1):109-17.

Chemical & Physical Properties

Density2.11g/cm3
Boiling Point628.1ºC at 760 mmHg
Molecular FormulaC6H8ClN7O
Molecular Weight229.62700
Flash Point333.7ºC
Exact Mass229.04800
PSA156.79000
LogP1.27100
Vapour Pressure1.08E-15mmHg at 25°C
Index of Refraction1.884
InChIKeyXSDQTOBWRPYKKA-UHFFFAOYSA-N
SMILESNC(N)=NC(=O)c1nc(Cl)c(N)nc1N

Safety Information

HS Code2934999090

Customs

HS Code2934999090
Summary2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Synonyms

Guanamprazine
Amipramizide
Amiloridum
Amipramidin
Amyloride
EINECS 220-024-7
MFCD00077316
AMILORIDE
Midamor
3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide
Guanamprazin
3,5-diamino-6-chloro-pyrazine-2-carboxylic acid carbamimidoylamide
Amipramizid
Amilorida
CAS 941943-17-5|(4-Methylpiperidin-1-yl)(5-(2-nitrophenyl)furan-2-yl)methanethione
CAS 941897-04-7|(4-Benzylpiperazin-1-yl)(5-(4-bromophenyl)furan-2-yl)methanethione
Recommended......
TOP